Announcements
Sidley Represents Clear Labs in Its US$30 Million Series D Financing
January 17, 2025
Sidley represented Clear Labs, a provider of fully automated, next-generation sequencing platforms for turnkey diagnostics, in its US$30 million Series D financing. The round was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, and funds and accounts advised by T. Rowe Price Associates, Inc.
The Sidley team was led by Carlton Fleming (Emerging Companies and Venture Capital) and included BinQuan Zhuang, Ph.D. (M&A), Daniel Wei (Emerging Companies and Venture Capital), and Benjamin Farkas (Securities Enforcement and Regulatory).
Capabilities
Suggested News & Insights
Sidley, Innovation Endeavors, and Premji Happy Hour Reception at JPMTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Represents Dechra in Acquisition of Gallant PetNovember 18, 2026Sidley Continues Strategic Growth of Global Life Sciences Practice With Addition of Corporate Lawyers Deepa Rich and Sam ZuckerNovember 18, 2026Sidley Represents RemeGen in Expanded US$356 Million Licensing Agreement With Vor BioNovember 16, 2026Sidley Represents Clearlake Capital Group in Mirendil’s US$1 Billion FinancingNovember 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
